Last $16.41 USD
Change Today +0.11 / 0.67%
Volume 196.0K
DRNA On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John J. Rossi Ph.D.

Co-Founder and Chairman of Scientific Advisory Board, Dicerna Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 88 board members in 6 different organizations across 10 different industries.

See Board Relationships
66--

Background*

Mr. John J. Rossi, Ph.D., is an Adjunct Professor, Division of Biomedical Sciences, University of California, Riverside, CA, as well as an Adjunct Professor, Department of Biochemistry and Microbiology, Loma Linda University, CA. Mr. Rossi is Co-Editor in chief of Nucleic Acid Therapeutics and Deputy Editor of Molecular Therapy. He also is an editor for JBC, Silence, BMC Biotechnology and Human Gene Therapy. His present focus is on enhancing the intracellular efficacy ...

Read Full Background

Corporate Headquarters*

Building 1
Watertown, Massachusetts 02472

United States

Phone: 617-621-8097
Fax: --

Board Members Memberships*

Director
2003-2010
Former Director, Member of Corporate Governance Committee and Member of Special Committee

Education*

PhD
University of Connecticut
Post-Doctoral Training
Brown University
BA
The University of New Hampshire, Durham

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DRNA:US $16.41 USD +0.11

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DICERNA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.